Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Becker

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
ACS Chemical Biology|November 1, 2012
Aminoglycoside antibiotics in the 21st centuryBernd Becker, Matthew A Cooper
Journal of Molecular Recognition : JMR|August 4, 2011
A survey of the 2006-2009 quartz crystal microbalance biosensor literatureBernd Becker, Matthew A Cooper
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2005
[Profiling methods in dermatology]Bernd Becker, Michael Landthaler, Thomas Vogt
Chemmedchem|September 20, 2006
Carbohydrates as scaffolds in drug discoveryWim Meutermans, Giang Thanh Le, Bernd Becker
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 25, 2006
Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancerChristian Hafner, Bernd Becker, Michael Landthaler, et al.
Mini Reviews in Medicinal Chemistry|December 16, 2006
Carbohydrate-based scaffolds in drug discoveryBernd Becker, Glenn C Condie, Giang Thanh Le, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 11, 2006
Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating neviAlexander Roesch, Sina Wittschier, Bernd Becker, et al.
Melanoma Research|September 27, 2003
Discrimination between gene expression patterns in the invasive margin and the tumour core of malignant melanomasAlexander Roesch, Thomas Vogt, Wilhelm Stolz, et al.
Oncology Reports|January 19, 2008
Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell linesAnnika Bundscherer, Christian Hafner, Tim Maisch, et al.
The Journal of Investigative Dermatology|April 29, 2006
Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cellsAlexander Roesch, Bernd Becker, Wulf Schneider-Brachert, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
ACS Chemical Biology|November 1, 2012
Aminoglycoside antibiotics in the 21st centuryBernd Becker, Matthew A Cooper
Journal of Molecular Recognition : JMR|August 4, 2011
A survey of the 2006-2009 quartz crystal microbalance biosensor literatureBernd Becker, Matthew A Cooper
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 17, 2005
[Profiling methods in dermatology]Bernd Becker, Michael Landthaler, Thomas Vogt
Chemmedchem|September 20, 2006
Carbohydrates as scaffolds in drug discoveryWim Meutermans, Giang Thanh Le, Bernd Becker
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 25, 2006
Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancerChristian Hafner, Bernd Becker, Michael Landthaler, et al.
Mini Reviews in Medicinal Chemistry|December 16, 2006
Carbohydrate-based scaffolds in drug discoveryBernd Becker, Glenn C Condie, Giang Thanh Le, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 11, 2006
Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating neviAlexander Roesch, Sina Wittschier, Bernd Becker, et al.
Melanoma Research|September 27, 2003
Discrimination between gene expression patterns in the invasive margin and the tumour core of malignant melanomasAlexander Roesch, Thomas Vogt, Wilhelm Stolz, et al.
Oncology Reports|January 19, 2008
Antiproliferative and proapoptotic effects of rapamycin and celecoxib in malignant melanoma cell linesAnnika Bundscherer, Christian Hafner, Tim Maisch, et al.
The Journal of Investigative Dermatology|April 29, 2006
Re-expression of the retinoblastoma-binding protein 2-homolog 1 reveals tumor-suppressive functions in highly metastatic melanoma cellsAlexander Roesch, Bernd Becker, Wulf Schneider-Brachert, et al.
Pageof 4